250 related articles for article (PubMed ID: 30276978)
21. Triphenylamine-appended cyclometallated iridium(III) complexes: Preparation, photophysical properties and application in biology/luminescence imaging.
Liu X; Hao H; Ge X; He X; Liu Y; Wang Y; Wang H; Shao M; Jing Z; Tian L; Liu Z
J Inorg Biochem; 2019 Oct; 199():110757. PubMed ID: 31445461
[TBL] [Abstract][Full Text] [Related]
22. Ferrocene-Appended Iridium(III) Complexes: Configuration Regulation, Anticancer Application, and Mechanism Research.
Ge X; Chen S; Liu X; Wang Q; Gao L; Zhao C; Zhang L; Shao M; Yuan XA; Tian L; Liu Z
Inorg Chem; 2019 Oct; 58(20):14175-14184. PubMed ID: 31559820
[TBL] [Abstract][Full Text] [Related]
23. Half-sandwich iridium N-heterocyclic carbene anticancer complexes.
Wang C; Liu J; Tian Z; Tian M; Tian L; Zhao W; Liu Z
Dalton Trans; 2017 May; 46(21):6870-6883. PubMed ID: 28405646
[TBL] [Abstract][Full Text] [Related]
24. Significant effects of counteranions on the anticancer activity of iridium(iii) complexes.
Zhang H; Guo L; Tian Z; Tian M; Zhang S; Xu Z; Gong P; Zheng X; Zhao J; Liu Z
Chem Commun (Camb); 2018 Apr; 54(35):4421-4424. PubMed ID: 29648559
[TBL] [Abstract][Full Text] [Related]
25. Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes.
Ma W; Zhang S; Tian Z; Xu Z; Zhang Y; Xia X; Chen X; Liu Z
Eur J Med Chem; 2019 Nov; 181():111599. PubMed ID: 31408807
[TBL] [Abstract][Full Text] [Related]
26. Anticancer application of ferrocene appended configuration-regulated half-sandwich iridium(III) pyridine complexes.
Wang Z; Lv Z; Liu X; Wu Y; Chang J; Dong R; Li C; Yuan XA; Liu Z
J Inorg Biochem; 2022 Dec; 237():112010. PubMed ID: 36152469
[TBL] [Abstract][Full Text] [Related]
27. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052
[TBL] [Abstract][Full Text] [Related]
28. Preparation and the anticancer mechanism of configuration-controlled Fe(II)-Ir(III) heteronuclear metal complexes.
Shao M; Liu X; Sun Y; Dou S; Chen Q; Yuan XA; Tian L; Liu Z
Dalton Trans; 2020 Sep; 49(36):12599-12609. PubMed ID: 32857087
[TBL] [Abstract][Full Text] [Related]
29. Similarities and differences in d
Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E
J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765
[TBL] [Abstract][Full Text] [Related]
30. The Fluorine Effect in Zwitterionic Half-Sandwich Iridium(III) Anticancer Complexes.
Yang Y; Guo L; Ge X; Zhu T; Chen W; Zhou H; Zhao L; Liu Z
Inorg Chem; 2020 Jan; 59(1):748-758. PubMed ID: 31808678
[TBL] [Abstract][Full Text] [Related]
31. Preparation and Bioactivity of Iridium(III) Phenanthroline Complexes with Halide Ions and Pyridine Leaving Groups.
Liu X; Shao M; Liang C; Guo J; Wang G; Yuan XA; Jing Z; Tian L; Liu Z
Chembiochem; 2021 Feb; 22(3):557-564. PubMed ID: 32964620
[TBL] [Abstract][Full Text] [Related]
32. Design and anticancer behaviour of cationic/neutral half-sandwich iridium(III) imidazole-phenanthroline/phenanthrene complexes.
Lv A; Li G; Zhang P; Tao R; Li X; Ren X; Li P; Liu X; Yuan XA; Liu Z
J Inorg Biochem; 2024 Aug; 257():112612. PubMed ID: 38761579
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological evaluation of iridium(III) complexes as potential antitumor agents.
Du F; Bai L; He M; Zhang WY; Gu YY; Yin H; Liu YJ
J Inorg Biochem; 2019 Dec; 201():110822. PubMed ID: 31536949
[TBL] [Abstract][Full Text] [Related]
34. Organometallic half-sandwich iridium anticancer complexes.
Liu Z; Habtemariam A; Pizarro AM; Fletcher SA; Kisova A; Vrana O; Salassa L; Bruijnincx PC; Clarkson GJ; Brabec V; Sadler PJ
J Med Chem; 2011 Apr; 54(8):3011-26. PubMed ID: 21443199
[TBL] [Abstract][Full Text] [Related]
35. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
[TBL] [Abstract][Full Text] [Related]
36. Ferrocene-modified half-sandwich iridium(III) and ruthenium(II) propionylhydrazone complexes and anticancer application.
Ji C; Dong R; Zhang P; Tao R; Wang X; Dai Q; Liu X; Yuan XA; Zhang S; Yue M; Liu Z
J Inorg Biochem; 2024 Aug; 257():112586. PubMed ID: 38728860
[TBL] [Abstract][Full Text] [Related]
37. Rhodamine-modified fluorescent half-sandwich iridium and ruthenium complexes: potential application as bioimaging and anticancer agents.
Ma W; Guo L; Tian Z; Zhang S; He X; Li J; Yang Y; Liu Z
Dalton Trans; 2019 Apr; 48(15):4788-4793. PubMed ID: 30892340
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and evaluation of fluorine and Naphthyridine-Based half-sandwich organoiridium/ruthenium complexes with bioimaging and anticancer activity.
Li J; Tian Z; Ge X; Xu Z; Feng Y; Liu Z
Eur J Med Chem; 2019 Feb; 163():830-839. PubMed ID: 30579123
[TBL] [Abstract][Full Text] [Related]
39. Carbene-anchored/pendent-imidazolium species as precursors to di-N-heterocyclic carbene-bridged mixed-metal complexes.
Zamora MT; Ferguson MJ; McDonald R; Cowie M
Dalton Trans; 2009 Sep; (35):7269-87. PubMed ID: 20449172
[TBL] [Abstract][Full Text] [Related]
40. DFT Investigation of the Mechanism of Action of Organoiridium(III) Complexes As Anticancer Agents.
Ritacco I; Russo N; Sicilia E
Inorg Chem; 2015 Nov; 54(22):10801-10. PubMed ID: 26492153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]